Financial Gravity Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Financial Gravity Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$110K	Buy	+3	New	+$311	0.05%	333
2019 Q4	–	Sell	-16	Closed	–	–	1847
2019 Q3	$0	Buy	16 +2	+14%	+$52	﹤0.01%	1714
2019 Q2	$0	Buy	14 +7	+100%	+$178	﹤0.01%	1849
2019 Q1	$0	Buy	+7	New	+$166	﹤0.01%	1644
2018 Q3	$2K	Buy	123 +20	+19%	+$380	﹤0.01%	1049
2018 Q2	$2K	Buy	103 +14	+16%	+$213	﹤0.01%	1068
2018 Q1	$1K	Buy	+89	New	+$1.31K	﹤0.01%	1352

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Financial Gravity Asset Management's HZNP Position: Q3 2021 in Review

Financial Gravity Asset Management opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2021: 3 shares worth $110K. The stake represents 0.05% of the portfolio and ranks #333 among its holdings. This is a return to the name: Financial Gravity Asset Management previously reported a position in HZNP as recently as Q3 2019.

Financial Gravity Asset Management first reported a position in HZNP in Q1 2018 and has held it in 7 quarters since. 572 funds tracked by Wall St. Rank hold HZNP as of Q3 2021.

Financial Gravity Asset Management held 3 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $110K as of Q3 2021.
Horizon Therapeutics Public Limited Company Ordinary Shares was a new Financial Gravity Asset Management position in Q3 2021.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.05% of Financial Gravity Asset Management's portfolio in Q3 2021, its #333 holding.
Financial Gravity Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2018 and has held it in 7 quarters since.
572 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2021.

Based on Financial Gravity Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.